C5AR1 and neoplasm: These findings indicate that the major target of the C5aR antagonist in tumor-bearing mice was MDSC, which could be a reasonable explanation for our observation that C5aR antagonism also worked in immunocompromised mice lacking mature T cells and functional Treg cells.